Plain English Summary
Background and study aims
Some people find wearing contact lenses can be uncomfortable, especially at the end of the day. At present, we do not know whether changes to the eye or to the contact lens are the most important factors in governing this discomfort. This project aims to improve our understanding in this area by assessing the effect of lens replacement and lens manipulation on the comfort of contact lenses.
Who can participate?
Adults who currently use daily disposable soft contact lenses and have used them for at least six months and have symptoms of discomfort at the end of the day
What does the study involve?
Volunteers will attend a clinic for six visits over four days. They will wear their habitual contact lenses during the course of the study. On day 1, volunteers will attend the clinic for an initial visit in which the investigator will confirm that they match the inclusion and exclusion criteria and will do an examination of the front surface of the eye. On days 2 and 3, volunteers will attend the clinic in the morning and 5 hours later. The investigator will randomly assign an intervention to each eye. In the morning, comfort scores will be collected before and after lens application. Volunteers will then leave the clinic and will be asked to wear their contact lenses in the normal way for at least 12 hours during which time they will provide comfort scores via SMS. Volunteers will return to the clinic 5 hours after lens application and the investigator will either replace the lens or manipulated the lens on-eye. The contact lens will not be manipulated in any way in the control group. Comfort scores will be collected at this time. Volunteers will then be asked to continue wearing their lenses and to provide comfort scores via SMS until they remove their lenses. On day 4, volunteers will attend the clinic for an exit visit in which they will receive an examination of the front surface of the eye and will then leave the study.
What are the possible benefits and risks of participating?
Benefits may include a thorough anterior eye examination and advice on contact lenses. All lens care products have the potential of causing serious injury to the eye. Due to the nature and duration of the study, the risks are judged to be similar to those of normal contact lens wear since subjects. It is possible that the following may occur with the use of contact lens products: pain, abrasion of the eyes, sensations of itching, burning or stinging, excessive tear production, unusual secretions, redness, reduced sharpness of vision, blurred vision, sensitivity to light or dry eyes. In rare instances, corneal ulcers, scarring, the growth of blood vessels into the cornea, temporary or permanent decreased vision, iritis and infections of the eye requiring treatment might occur. Major side effects from the use of diagnostic dye sodium fluorescein are very rare, but there are three reports of anaphylaxis following topical instillation of fluorescein. Anaphylaxis can result in death but none of the reported cases to date has been fatal. Other rare side effects from the topical use of sodium fluorescein can include slight stinging on instillation and temporary blurred vision.
Where is the study run from?
Eurolens Research at the University of Manchester (UK)
When is the study starting and how long is it expected to run for?
From February 2013 to March 2014
Who is funding the study?
Investigator initiated and funded
Who is the main contact?
Miss Maria Navascues-Cornago
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
ER13-541
Study information
Scientific title
Effect of three interventions on contact lens comfort in symptomatic wearers: a randomised single-blind study
Acronym
Study hypothesis
To investigate the effect of replacing the lens with the same or with a new lens and performing a scleral swish part way through the day on comfort in symptomatic daily disposable soft contact lens wearers.
Ethics approval
University of Manchester Committee on the Ethics of Research on Human Beings, 07/06/2013, ref: 13009
Study design
Interventional randomised controlled single-blind single-centre trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Condition
Contact lens comfort
Intervention
Subjects will attend the clinic on two study days. On each day, subjects attended the clinic in the morning without any lenses in situ (and not having worn lenses beforehand on the day). A new pair of their habitual daily disposable lenses was applied directly from the packaging solution and worn for at least 12 hours. Comfort scores were recorded before lens application and 6 minutes post-application using the 0 to 100 grading scale. Automated short message service (SMS) text messages via mobile phone were sent to subjects every hour following lens application requesting a comfort score using the same scale. Five hours after lens application, the investigator performed one of three interventions on each eye together with a control:
1. Replacement of the existing lens with a new lens: the existing lens will be removed and a new, fresh contact lens will be re-applied directly from the packaging solution
2. Removal of the existing lens and re-application of the same lens: the existing lens will be removed and placed in a lens case containing 0.9% sterile saline (Eye Care solutions, Crest Medical Ltd, Warrington, UK) and then re-applied
3. A scleral swish: the contact lens will be slid off the cornea onto the temporal conjunctiva; subjects will then be asked to fully blink five times, and then the lens will be slid back onto the cornea
4. No action (control): the contact lens will not be manipulated in any way
The interventions will be randomly assigned to each eye (i.e., each eye will receive a different intervention) and subjects will be masked to whether the re-applied lens is a new lens or the same lens. The investigator will generate the randomisation scheme using the web site Randomization.com (http://www.randomization.com), which creates random permutations of interventions for a situation where subjects are to receive all of the interventions in random order.
Intervention type
Other
Phase
Drug names
Primary outcome measures
1. Contact lens comfort score will be measured with an annotated vertical analogue comfort scale of 0 (causes pain, cannot be tolerated) and 100 (excellent, cannot be felt) and recorded on paper before lens application, 5 hours post-application, and 6 minutes post-intervention
2. Comfort scores at 6 minutes post-application and at every hour following lens application will be collected through SMS messaging using the same scale; only SMS comfort scores received within 30 minutes from the target time will be included in the analysis
Secondary outcome measures
None
Overall trial start date
04/02/2013
Overall trial end date
05/03/2014
Reason abandoned
Eligibility
Participant inclusion criteria
1. At least 18 years old and capacity to volunteer
2. Understand rights as a research subject
3. Willing and able to
sign a statement of informed consent
4. Willing and able to follow the protocol
5. Agree not to participate in other clinical research for the duration of this study
6. Wear daily disposable soft contact lenses and have worn them for at least 6 months
7. Symptomatic according to method by Young et al (Characterizing contact lens-related dryness symptoms in a cross-section of UK soft lens wearers. Contact Lens and Anterior Eye 2011; 34: 64–70)
8. Willing to wear contact lenses for at least 12 hours a day
9. Having a mobile phone
Participant type
Healthy volunteer
Age group
Adult
Gender
Both
Target number of participants
30
Participant exclusion criteria
1. Systemic or ocular disorder that might affect ocular health
2. Grade 2 or greater of any anterior ocular clinical signs
3. Use of any topical medication, such as eye drops or ointment
4. Previous cataract or corneal refractive surgery
5. Corneal distortion resulting from previous hard or rigid lens wear or keratoconus
6. Pregnant or lactating
7. Diabetes
8. Infectious disease (e.g., hepatitis)
9. Immunosuppressive disease (e.g., HIV)
10. History of severe allergic reaction or anaphylaxis (a serious form of hypersensitivity that can, in rare cases, result in death)
11. Unacceptable lens fit (grade –2 or +2 on a –2 to +2 grading scale)
12. Participation in other clinical trial or research within 2 weeks before starting this study
Recruitment start date
21/08/2013
Recruitment end date
17/02/2014
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Eurolens Research, University of Manchester
Manchester
M13 9PL
United Kingdom
Funders
Funder type
Not defined
Funder name
Investigator initiated and funded
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
The results of this study are intended to be published in a scientific journal in the near future (to be confirmed at a later date)
Intention to publish date
Participant level data
Not expected to be available
Results - basic reporting
Publication summary
2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26267853